Carson Wealth (CWM LLC)
RNAC icon

Carson Wealth (CWM LLC)’s Cartesian Therapeutics RNAC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.5K Buy
4,636
+4,445
+2,327% +$31.7K ﹤0.01% 4199
2025
Q4 		$1K Sell
191
-63
-25% -$509 ﹤0.01% 5271
2025
Q3 		$3K Sell
254
-299
-54% -$3.36K ﹤0.01% 4933
2025
Q2 		$6K Buy
553
+161
+41% +$1.72K ﹤0.01% 4561
2025
Q1 		$5K Buy
392
+312
+390% +$5.57K ﹤0.01% 4484
2024
Q4 		$1K Buy
80
+64
+400% +$1.3K ﹤0.01% 4787
2024
Q3 		$0 Buy
16
+12
+300% +$187 ﹤0.01% 5101
2024
Q2 		$0 Buy
+4
New +$95 ﹤0.01% 4890
2024
Q1 		– Hold
0
– – – 4688
2023
Q2 		– Hold
0
– – – 4429
2023
Q1 		– Hold
0
– – – 4307
2022
Q4 		– Hold
0
– – – 4214
2022
Q3 		– Hold
0
– – – 4151

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RNAC Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Cartesian Therapeutics (RNAC) stake by 2,327% in Q1 2026, buying an estimated $31.7K and bringing the position to 4,636 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4199.

Carson Wealth (CWM LLC) first reported a position in RNAC in Q2 2024 and has held it in 8 quarters since. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Carson Wealth (CWM LLC) held 4,636 shares of Cartesian Therapeutics worth $28.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 4,445 Cartesian Therapeutics shares in Q1 2026, an estimated $31.7K.
  • Cartesian Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4199 holding.
  • Carson Wealth (CWM LLC) first reported a position in Cartesian Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.